Repositioning Candidate Details
| Candidate ID: | R0772 |
| Source ID: | DB05326 |
| Source Type: | investigational |
| Compound Type: | small molecule |
| Compound Name: | INKP-102 |
| Synonyms: | -- |
| Molecular Formula: | -- |
| SMILES: | -- |
| DrugBank Description: | INKP-102 is the next generation sodium phosphate tablet designed to aid bowl preparation before colonoscopy. |
| CAS Number: | -- |
| Molecular Weight: | |
| DrugBank Indication: | Investigated for use/treatment in gastrointestinal diseases and disorders (miscellaneous). |
| DrugBank Pharmacology: | -- |
| DrugBank MoA: | INKP-102 tablets are smaller in size and easier to swallow than the Company's currently marketed sodium phosphate tablet product, Visicol. The new INKP-102 tablets contain no microcrystalline cellulose (MCC), an inert, but highly insoluble, tablet binder. |
| Targets: | -- |
| Inclusion Criteria: | Indication associated |
| Strategy ID | Strategy | Synonyms | Related Targets | Related Drugs |
|---|